India, April 7 -- image credit- shutterstock

India is evolving in its biotechnology and pharmaceutical journey. As the world looks toward building more resilient, intelligent, and decentralised supply chains, India's aspiration to lead in biomanufacturing is stronger than ever.

Central to this transformation is the rise of predictive technologies where artificial intelligence, sensor networks, and digital twins allow for real-time monitoring, simulation, and optimization of pharmaceutical manufacturing processes. These tools promise cleaner batches, faster responses to deviations, and smarter decision-making across production lines. For large pharmaceutical corporations, adopting these technologies is already underway.

But for India to...